Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. BioGaia ...
BioGaia AB (NASDAQ: BIOG) has signed a renewed distribution agreement with Ewopharma. The extended agreement reinforces the companies' successful collaboration to date and reflects a shared ambition t ...
BioGaia's probiotics have received top ratings and the company has seen rapid growth, but concerns are raised about the company's ability to maintain this amidst leadership changes. The company ...
Overview: BioGaia AB (publ) is a healthcare company that develops, manufactures, markets, and sells probiotic products for gut, oral, and immune health across various regions including Europe, the ...
Welcome to BioGaia Q3 Report for 2025. [Operator Instructions] Now I will hand the conference over to CEO, Theresa Agnew; and CFO, Alexander Kotsinas. Please go ahead. Hi. This is Theresa Agnew, CEO ...
Revenue: SEK 304 million, a decline of 4%. EBIT: SEK 41 million, a decline of 65%. Adjusted EBIT: SEK 93 million, a decline of 22%. EBIT Margin: 14%. Adjusted EBIT Margin: 31%. Earnings Per Share: SEK ...
Infant Bacterial Therapeutics (IBT), a subsidiary of BioGaia, today announced that the IND (Investigational New Drug) for the prevention of necrotizing enterocolitis (NEC), has been accepted by the ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...
The Swedish company recently hired its first ANZ marketing director after relaunching into the market as a standalone brand. BioGaia, which claims it is a leader in probiotic innovation backed by ...
Stockholm-based private equity company EQT is to take a minority in the Swedish probiotic food supplement firm BioGaia. As part of a directed issue, and subject to the approval of BioGaia shareholders ...